These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 5848044)

  • 1. An experimental evaluation of the reputed influence of thyroxine on the cardiovascular effects of catecholamines.
    van der Schoot JB; Moran NC
    J Pharmacol Exp Ther; 1965 Sep; 149(3):336-45. PubMed ID: 5848044
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronotropic action of thyroid hormones on the heart and catecholamines].
    Kandror VI; Shakhnarovich VM
    Dokl Akad Nauk SSSR; 1970 May; 192(2):455-7. PubMed ID: 5457961
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the relationships between some metabolic effects of thyroid hormones and catecholamines in animals and man.
    Svedmyr N
    Acta Physiol Scand Suppl; 1966; 274():1-46. PubMed ID: 5936359
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of thyroxine on rat heart adenosine 3',5'-monophosphate, phosphorylase b kinase and phosphorylase a activity.
    Frazer A; Hess ME; Shanfeld J
    J Pharmacol Exp Ther; 1969 Nov; 170(1):10-6. PubMed ID: 4390812
    [No Abstract]   [Full Text] [Related]  

  • 5. [Permissive effect of thyroid hormones on calorigenesis of catecholamines].
    Kurahashi M
    Nihon Seirigaku Zasshi; 1972; 34(1):1-7. PubMed ID: 5064131
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of triiodothyronine on hemodynamic responses to epinephrine and norepinephrine in man.
    Aoki VS; Wilson WR; Theilen EO; Lukensmeyer WW; Leaverton PE
    J Pharmacol Exp Ther; 1967 Jul; 157(1):62-8. PubMed ID: 6029492
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular system reactivity to catecholamines during ontogenetic development of dogs and rats.
    Brus R; Lenartowicz H; Korczak-Dziuba K; Monsiol A; Kmieciak-Kolada K; Jamrozik Z
    Acta Physiol Pol; 1975; 26(6):543-51. PubMed ID: 1108594
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic treatment with catecholamines and the cardiovascular system.
    LeBlanc J; Vallières J; Bureau M; Labrie A; Deshaies Y; Vachon C
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():527-32. PubMed ID: 4806666
    [No Abstract]   [Full Text] [Related]  

  • 9. Response of rat atrium to propranolol and catecholamines in various states of thyroid action.
    Hirvonen L; Paavilainen TO
    Acta Physiol Scand; 1967 Apr; 69(4):284-94. PubMed ID: 6033666
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of thyroid gland function on the pharmacological action of propranolol, adrenaline, noradrenaline and dinitrophenol].
    Strubelt O
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):263-88. PubMed ID: 5715404
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the cardiovascular effects of synthetic vasopressin.
    Nakano J
    J Pharmacol Exp Ther; 1967 Jul; 157(1):19-31. PubMed ID: 6029485
    [No Abstract]   [Full Text] [Related]  

  • 12. [Do catecholamines increase basal metabolism?].
    Strubelt O
    Arzneimittelforschung; 1968 Jun; 18(6):724-9. PubMed ID: 5755811
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of adrenaline on the oxygen consumption of thyroidectomized rats chronically treated with thyroid hormones].
    Michel R; Bouhnik J; Michel O
    C R Seances Soc Biol Fil; 1968; 162(12):2104-6. PubMed ID: 4241514
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of the reputed augmentation of the cardiovascular effects of catecholamines in patients with spontaneous hyperthyroidism.
    Aoki VS; Wilson WR; Theilen EO
    J Pharmacol Exp Ther; 1972 May; 181(2):362-8. PubMed ID: 5030676
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenergic cardiovascular actions in rats as affected by dichloromethane exposure.
    Müller S; Weise M; Krug T; Hoffmann P
    Biomed Biochim Acta; 1991; 50(3):307-11. PubMed ID: 1953698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The circulatory effects of catecholamines and ouabain in glucocorticoid-deficient animals.
    Cueto C; Moran NC
    J Pharmacol Exp Ther; 1968 Nov; 164(1):31-44. PubMed ID: 4301845
    [No Abstract]   [Full Text] [Related]  

  • 17. Dominance of lipid metabolism in the myocardium under the influence of 1-norepinephrine.
    Regan TJ; Moschos CB; Oldewurtel HA; Weisse AB; Asokan SK
    J Lab Clin Med; 1967 Aug; 70(2):221-8. PubMed ID: 6029054
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile.
    Charlier R; Deltour G; Baudine A; Chaillet F
    Arzneimittelforschung; 1968 Nov; 18(11):1408-17. PubMed ID: 5755904
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of injected norepinephrine and sympathetic nerve stimulation in hypothyroid and hyperthyroid dogs.
    Margolius HS; Gaffney TE
    J Pharmacol Exp Ther; 1965 Sep; 149(3):329-35. PubMed ID: 5848043
    [No Abstract]   [Full Text] [Related]  

  • 20. The action of protriptyline on peripheral autonomic function.
    Cairncross KD; McCulloch MW; Mitchelson F
    J Pharmacol Exp Ther; 1965 Sep; 149(3):365-72. PubMed ID: 5848047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.